0.51% 0.0101

Fortress Biotech Inc (FBIO)

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Fortress Biotech Inc Stock (FBIO) Company Profile

Fortress Biotech Inc

781-652-4500

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Nächster Verdiensttermin

Neueste SEC-Einreichungen

FBIO's Discussions on Twitter

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-08-04	Eingeleitet	Ladenburg Thalmann	Buy
2020-10-02	Eingeleitet	The Benchmark Company	Buy
2019-12-18	Eingeleitet	B. Riley FBR	Buy
2018-02-28	Eingeleitet	B. Riley FBR, Inc.	Buy
2017-07-11	Eingeleitet	Rodman & Renshaw	Buy
2017-03-22	Eingeleitet	JMP Securities	Mkt Outperform
2016-10-03	Eingeleitet	ROTH Capital	Buy

Alle ansehen

Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten

Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)

Fortress Biotech Inc-Aktie (FBIO) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Jin David	Chief Financial Officer	Jul 10 '24	Buy	7.50	500	3,750	500
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Jul 09 '24	Buy	7.39	5,000	36,971	122,500
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Jul 08 '24	Buy	7.35	5,000	36,764	117,500
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Jun 28 '24	Buy	1.64	20,000	32,724	2,893,905
ROSENWALD LINDSAY A MD	President, CEO & Chairman	May 16 '24	Buy	1.76	10,000	17,589	2,873,905
Klein Dov	Director	May 20 '24	Sale	1.89	10,000	18,900	53,400
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Jan 05 '24	Buy	2.38	50,000	118,770	2,863,905
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Nov 14 '23	Buy	1.70	1,567,515	2,664,776	2,597,440
WEISS MICHAEL S	See Remarks	Nov 14 '23	Buy	1.70	147,058	249,999	1,130,520
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Sep 26 '23	Buy	0.28	100,000	28,330	15,449,091

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc Stock (FBIO) Company Profile

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten

Checkpoint Therapeutics Announces Cosibelimab Longer-Term - GlobeNewswire

Fortress Biotech Inc (FBIO) receives a Buy rating from ROTH MKM - Knox Daily

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference - StockTitan

Fortress Biotech Pref A stock hits 52-week low at $6.06 - Investing.com Canada

Fortress Biotech Inc [FBIO] President, CEO & Chairman makes an insider purchase of 5,000 shares worth 37418.0. - Knox Daily

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com

Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Does Fortress Biotech Inc (FBIO) offer a good opportunity for investors? - SETE News

Fortress Biotech (FBIO) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance

Fortress Biotech, India Fund, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency

Long Term Trading Analysis for (FBIOP) - Stock Traders Daily

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024 - MSN

Fortress Biotech (STU:CNB1) 9-Day RSI : N/A (As of Aug. 20, 2024) - GuruFocus.com

Fortress Biotech (STU:CNB1) 9-Day RSI : N/A (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) 14-Day RSI : 43.84 (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) Volatility : 47.06% (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB0.PFD) EBITDA per Share : €0.00 (TTM As of Jun. 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) GF Value Rank : 2 (As of Aug. 18, 2024) - GuruFocus.com

Fortress Biotech, B. Riley Financial, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency

FBIOP.PFD (Fortress Biotech) EV-to-Revenue : 0.00 (As of Aug. 17, 2024) - GuruFocus.com

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com India

Fortress Biotech (STU:CNB1) Inventory-to-Revenue : 0.68 (As of Jun. 2024) - GuruFocus.com

Fortress Biotech (STU:CNB1) PE Ratio (TTM) : At Loss (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) Cash Flow for Lease Financing : €0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com Canada

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com Australia

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com UK

Fortress Biotech, Inc. to Post Q3 2024 Earnings of ($0.27) Per Share, Roth Capital Forecasts (NASDAQ:FBIO) - Defense World

Fortress Biotech (NASDAQ:FBIO) Upgraded by StockNews.com to Hold - Defense World

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com India

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com Australia

Understanding the Risks of Investing in Fortress Biotech Inc (FBIO) - Knox Daily

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com Canada

Fortress Biotech: Q2 Earnings Snapshot - Darien Times

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com UK

Fortress Biotech: Q2 Earnings Snapshot - San Antonio Express-News

Fortress Biotech: Q2 Earnings Snapshot - New Haven Register

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace

Fortress Biotech: Q2 Earnings Snapshot - San Francisco Chronicle

Fortress Biotech: Q2 Earnings Snapshot - Thehour.com

Fortress Biotech: Q2 Earnings Snapshot - Houston Chronicle

Fortress Biotech (FBIO) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - StockTitan

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - StockTitan

Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewswire

Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates - StockTitan

Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Fortress Biotech Inc-Aktie (FBIO) Insiderhandel

Ähnlich wie FBIO